
Anthropic has launched Claude Tag, a new AI service for Slack that acts as a persistent AI teammate. This service allows users to tag @Claude for insights and task assignments, maintaining a continuous memory of channel activities. Claude Tag can access and gather information from various channels, enhancing its contextual understanding. This development aims to improve collaboration by providing a single AI identity that can track and update ongoing projects within Slack. The feature is available in beta for Claude Enterprise and Claude Team customers.
Read originalEarlier coverage that leads up to this article, and what followed. Lines connect each piece to the closest one after it, converging here.
© TechCrunch AIxAI's attempt to dismiss the NAACP's Clean Air Act lawsuit failed after a federal judge ruled that its gas turbines are not exempt mobile sources and that plaintiffs have standing. This legal setback confirms that AI infrastructure operators cannot bypass environmental permitting by classifying heavy industrial equipment as temporary or mobile. The ruling forces xAI to face scrutiny over air quality impacts at its Colossus data center, setting a precedent for how large-scale compute facilities are regulated under existing environmental laws.
© TechCrunch AIThe Rundown AI · April 20, 2026 · Related
Duncan Rogoff · April 20, 2026 · Related
Fireship · April 21, 2026 · Related
Matt Wolfe · April 24, 2026 · Related
MIT Technology Review AI · May 21, 2026 · Related
AI News · May 29, 2026 · Related
Anthropic · June 3, 2026 · Same story
Duncan Rogoff · June 19, 2026 · Related
Anthropic · July 9, 2026 · Same story
TechCrunch AI · July 23, 2026 · Related
The Verge AI · August 20, 2026 · Same story
TechCrunch AI · August 25, 2026 · Same story
Skill Leap AI · October 20, 2026 · Same story
Anthropic Launches Claude Tag for Slack
5 developments
OpenAI is scaling back its ambitions as investor appetite for massive AI infrastructure bets cools. The company has lowered its fundraising target from $30 billion to $20 billion, with only $11 billion secured so far against a valuation that has dropped from $1.4 trillion. This retreat signals a growing wariness among Wall Street investors regarding the capital intensity of the AI race, forcing even the most dominant players to adjust their financial expectations.
Exin Therapeutics has demonstrated an AI agent physically controlling a robotic arm to inject drugs into a live mouse's brain. The experiment reveals a critical divergence in model behavior: Anthropic’s Claude Opus refused the procedure due to safety concerns, while Sonnet proceeded. This suggests that as agents gain direct access to physical lab equipment, their alignment and refusal mechanisms become operational realities rather than theoretical safeguards. It marks a shift from AI merely analyzing data to actively manipulating biological systems under human supervision. The team initially tested Claude Opus 5.5, but it halted the injection, citing potential harm. Switching to Claude Sonnet 5 allowed the procedure to complete, though with delays caused by coordinate system glitches. A secondary Opus agent had to fix code errors without knowing a live surgery was underway. Human oversight remains essential as researchers test more complex tasks like craniotomies.